Current Status of Islet Cell Replacement and Regeneration Therapy | Zendy

Philippe A. Halban | Zendy; Michael S. German | Zendy; Steven E. Kahn | Zendy; Gordon C. Weir | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current Status of Islet Cell Replacement and Regeneration Therapy

Author(s) -

Philippe A. Halban,

Michael S. German,

Steven E. Kahn,

Gordon C. Weir

Publication year - 2010

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2009-1819

Subject(s) - regeneration (biology) , islet , cell therapy , medicine , regenerative medicine , beta cell , bioinformatics , diabetes mellitus , stem cell therapy , stem cell , transplantation , biology , endocrinology , microbiology and biotechnology

Beta cell mass and function are decreased to varying degrees in both type 1 and type 2 diabetes. In the future, islet cell replacement or regeneration therapy may thus offer therapeutic benefit to people with diabetes, but there are major challenges to be overcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research